Related Experiment Videos
Weekly chemotherapeutic regimen in metastatic prostate cancer
1Department of Medical Oncology, Farmitalia Freiburg, FRG.
Progress in Clinical and Biological Research
|January 1, 1990
Abstract:
1. A weekly fractionation of EPIRUBICIN at an unchanged dose intensity leads to a significant decrease in toxicity. 2. The weekly administration of 25 mg/m2 EPIRUBICIN is effective in treating hormone refractory prostate carcinoma and completely fulfills the requirements for palliation.